Palladio Biosciences, Inc., a Centessa company
Palladio Biosciences, Inc., is a Centessa company. Our first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes num...load more
Palladio Biosciences, Inc., a Centessa company's Basic Information
Industry
Headquarters
Horsham, Pennsylvania, United States
Website
Founded Year
2015
Headcount
2 - 10 ( View All )
Specialties
Renal DiseaseKidney DiseasePolycystic Kidney DiseasePKDADPKDARPKDNephrologyOrphanRareGenetic Disease
Palladio Biosciences, Inc., a Centessa company's Competitors
Employee Insights
Palladio Biosciences, Inc., a Centessa company's Top Employees
Frequently Asked Questions Regarding Palladio Biosciences, Inc., a Centessa company
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts